日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucidinostat Plus R-CHOP vs R-CHOP in MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Randomized Clinical Trial

Tucidinostat Plus R-CHOP vs R-CHOP 治疗 MYC/BCL2 双表达弥漫性大 B 细胞淋巴瘤:一项随机临床试验

Xu, Peng-Peng; Song, Yu-Qin; Shen, Jian-Zhen; Cai, Qing-Qing; Zhou, Hui; Zhang, Li-Ling; Xiang, Ying; Sun, Xiu-Hua; Yang, Wei; Yao, Zhi-Hua; Jing, Hong-Mei; Wen, Shu-Juan; Jin, Jie; Xue, Hong-Wei; Cen, Hong; Ding, Kai-Yang; Jin, Zheng-Ming; Liu, Li-Hong; Xing, Xiao-Jing; Li, Lan-Fang; Hou, Ming; Liu, Lin; Zhang, Ming-Zhi; Li, Wen-Yu; Bai, Ou; Feng, Ru; Zhu, Zun-Min; Wu, Hui-Jing; Su, Li-Ping; Gao, Li; Li, Fei; Huang, Wen-Rong; Liu, Peng; Yan, Xiao-Jing; Zhao, Ying; Su, Hang; Zhao, Xie-Lan; Fu, Rong; Liu, Hong; Shi, Wen-Yu; Li, Hui-Zhi; Chen, Bo; Ning, Zhi-Qiang; Zhu, Jun; Zhao, Wei-Li

The "cytokine storm" in infection and sepsis: win the battle but lose the war

感染和脓毒症中的“细胞因子风暴”:赢得战斗却输掉战争

Fan, Jiang-Bo; Li, Qin-Yuan; Feng, Xi-Feng; Huang, Si-Yuan; Wang, Rui; Liao, Feng-Ying; Liu, Di; Liu, Wen-Yi; Sun, Jian-Hui; Zhang, Hua-Cai; Zhou, Hui-Ting; Jiang, Jian-Xin; Wang, Zhen; Zeng, Ling

Spatiotemporal evaluation of antithrombotic performance for biomaterials through monitoring β-sheet conformation changes at the blood interface

通过监测血液界面处β折叠构象变化,对生物材料的抗血栓性能进行时空评估

Zhou, Hui; Xu, Yizhou; Zhang, Shuxiang; Fan, Jierui; Wei, Qiang; Zhao, Changsheng

The Catalytic Asymmetric Mukaiyama-Michael Reaction of Silyl Ketene Acetals with Cyclic Enones: Short Routes to Jasmonates

硅烯酮缩醛与环状烯酮的催化不对称Mukaiyama-Michael反应:茉莉酸酯的简便合成路线

Xu, Ruigang; Zhou, Hui; Bae, Han Yong; Wakchaure, Vijay N; Baldinelli, Lorenzo; Leach, Isaac F; Bistoni, Giovanni; Kraft, Philip; List, Benjamin

Targeting IL27RA Enhances Immunotherapy in Triple-Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment.

靶向 IL27RA 通过调节肿瘤细胞和肿瘤微环境增强三阴性乳腺癌的免疫疗法。

Xu Jiachi, Long Qian, Zhou Meirong, Chen Qitong, Peng Jing, Liang Qingchun, Zhang Danhua, Zhou Hui, Yi Wenjun

Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)

针对接受一线全身治疗后外周T细胞淋巴瘤患者的 JAK1 选择性抑制剂 golidocitinib 的 II 期多中心维持治疗研究 (JACKPOT26)

Wei, Juying; Cai, Qingqing; Zhang, Liling; Zou, Liqun; Li, Zengjun; Zhou, Keshu; Wu, Huijing; Qiu, Lihua; Su, Liping; Ding, Kaiyang; Zhou, Hui; Yu, Li; Li, Fei; Li, Wenyu; Lin, Li'e; Xiao, Qing; Wang, Erhua; Jing, Hongmei; Zheng, Meifang; Zhang, Hongyu; Gao, Yuhuan; Gao, Da; Chen, Lijia; Jin, Jie

Protein Lactylation in Cancer: Mechanisms and Therapeutic Targets

癌症中的蛋白质乳化:机制和治疗靶点

Ouyang, Qianying; Hu, Qianyu; Wang, Caiqin; He, Yizi; Zeng, Ruolan; Li, Yajun; Su, Chang; Lu, Guige; Zhu, Xueting; Xiao, Ling; Zhou, Hui

Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trial

抗TIM-3抗体TQB2618联合penpulimab治疗既往接受过PD-1/PD-L1靶向治疗的复发或难治性经典霍奇金淋巴瘤:一项多中心、开放标签、单臂Ib期临床试验

Hong, Huangming; Chen, Zegeng; Cui, Jie; Zhang, Qingyuan; Li, Ping; Tao, Rong; Huang, He; Wang, Binghua; Li, Wuping; Wu, Hui; Wei, Jin; Su, Liping; Zhang, Zhihua; Zhong, Mingxing; Wang, Huaqing; Wang, Cong; Zhou, Hui; Wang, Jishi; Dong, Min; Lin, Tongyu

Editing of an antiviral host factor boosts plant growth and yield of plant viral vector-mediated heterologous protein expression

编辑抗病毒宿主因子可促进植物生长并提高植物病毒载体介导的异源蛋白表达的产量

Fang, Zhu; Zhao, Xinru; Du, Min; Xu, Xinyi; Zhou, Hui; Guo, Wei; Zhou, Xueping; Yang, Xiuling

CBX8 suppresses autophagy-dependent senescence in colorectal cancer by modulating the mTOR signaling pathway

CBX8通过调节mTOR信号通路抑制结直肠癌细胞的自噬依赖性衰老

Li, Tiankang; Zhang, Enjian; Liu, Xin; Zhou, Hui; Zhang, Pengbo; Zhang, Chong; Zhang, Xiuzhong; Wu, Nai; Gong, Shuai; Ren, Zeqiang; Ding, Jie; Zhang, Yi